Delivery Order SPE2DB20D1051-SPE2DB24FD7RH
- Not listed
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 MCG Inhaler, 12GM. The contract has a ceiling value of $1,540.05 and a period of performance through August 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Advair HFA 115-21 mcg inhalers. The contract has a total ceiling value of $5,189.83 and a period of performance through April 5, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, with a potential value of $999,999,999.00 and a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Advair HFA 115-21 MCG Inhaler in 12 gram quantities, with a ceiling value of $3,856.08 and a performance period through June 3, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Advair HFA 45-21 mcg inhalers. The order, valued at $5,493.84, is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of Advair HFA 115-21 mcg inhalers, with a ceiling value of $4,055.75 and a period of performance ending on March 28, 2024. This order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a specialty pharmaceutical product, with a ceiling value of $58,387.65 and a period of performance through March 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Amerisourceberen Corporation, to provide Advair HFA 230-21 mcg Inhaler 12 gm. The contract has a ceiling value of $11,587.23 and a performance period through April 9, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order is for the supply of Advair HFA 115-21 mcg inhalers with a ceiling value of $5,605.48 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The award has a completion date of March 7, 2024 and a potential value of $7,425.04. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. The contract is issued under a larger...
- This is a $1,068.57 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Advair HFA 115-21 mcg inhalers. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD7RHDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product, with a ceiling value of $1,155.22 and a performance period through April 9, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and is an experienced provider of pharmaceuticals and medical supplies to the Department of Defense, regularly receiving awards from DLA Troop Support Medical. This delivery order is issued under a larger, single-award Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential total value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of medications and healthcare materials to military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/8/24 |